Virology, Simian immunodeficiency virus, Virus, Immunology and Viral replication are her primary areas of study. Her biological study spans a wide range of topics, including Genetics, Antibody and Immunodeficiency. Vanessa M. Hirsch interconnects Simian, T cell, Acquired immunodeficiency syndrome, Viral load and African Green Monkey in the investigation of issues within Simian immunodeficiency virus.
Her work in Virus addresses issues such as Lymph, which are connected to fields such as Homing, Simian Acquired Immunodeficiency Syndrome and Lymph node. Her Viral replication study combines topics in areas such as Gastrointestinal tract and Chromosomal translocation. Her research investigates the connection with Viremia and areas like Vaccinia which intersect with concerns in CTL*.
Her main research concerns Virology, Simian immunodeficiency virus, Virus, Immunology and Viral replication. Her Virology research focuses on subjects like Immunodeficiency, which are linked to Acquired immunodeficiency syndrome. Her Simian immunodeficiency virus research focuses on African Green Monkey and how it relates to Cercopithecus aethiops.
Her work deals with themes such as Vaccinia and Polymerase chain reaction, which intersect with Virus. Her Immunology study frequently draws connections between adjacent fields such as Cytotoxic T cell. Her study in Viral replication is interdisciplinary in nature, drawing from both Peripheral blood mononuclear cell, Mutant and In vivo.
The scientist’s investigation covers issues in Virology, Simian immunodeficiency virus, Virus, Immunology and Viral load. Her Virology research incorporates elements of Antibody, Immune system and In vivo. Her Simian immunodeficiency virus study is concerned with Genetics in general.
Her Virus study combines topics from a wide range of disciplines, such as Gp41, Monoclonal antibody and Rhesus macaque. Her work carried out in the field of Immunology brings together such families of science as Vector and Central nervous system. Her Viral load study incorporates themes from Pathology, CD14, Proinflammatory cytokine, Macrophage and Glucocorticoid.
Vanessa M. Hirsch mostly deals with Virology, Simian immunodeficiency virus, Virus, Immunology and Viral replication. Her Virology research is multidisciplinary, incorporating perspectives in Cercocebus torquatus and In vivo. Her Simian immunodeficiency virus study necessitates a more in-depth grasp of Genetics.
Virus is closely attributed to Cell type in her work. The Viral replication study combines topics in areas such as Cell, Haematopoiesis, Disease reservoir, Oncovirus and African Green Monkey. Her research integrates issues of Vaccinia, Canarypox virus and Vector in her study of Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An African primate lentivirus (SIVsm) closely related to HIV-2
Vanessa M. Hirsch;Robert A. Olmsted;Michael Murphey-Corb;Robert H. Purcell.
Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections
Jacob D. Estes;Levelle D. Harris;Nichole R. Klatt;Brian Tabb.
PLOS Pathogens (2010)
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
Tatsuhiko Igarashi;Charles R. Brown;Yasuyuki Endo;Alicia Buckler-White.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield.
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
V M Hirsch;T R Fuerst;G Sutter;M W Carroll.
Journal of Virology (1996)
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.
Yoshinori Fukazawa;Richard Lum;Afam A Okoye;Haesun Park.
Nature Medicine (2015)
ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency
R. Pal;D. Venzon;N. L. Letvin;S. Santra.
Journal of Virology (2002)
Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses
Robert A. Olmsted;Vanessa M. Hirsch;Robert H. Purcell;Philip R. Johnson.
Proceedings of the National Academy of Sciences of the United States of America (1989)
CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain
Aimee L. Edinger;Joseph L. Mankowski;Benjamin J. Doranz;Barry J. Margulies.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection.
Martin A. Nowak;Alun L. Lloyd;Gabriela M. Vasquez;Theresa A. Wiltrout.
Journal of Virology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: